Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mohit K Turagam Added: 1 year ago
AF Symposium 2024 – In this interview, investigator Dr Mohit K Turagam (Icahn School of Medicine at Mount Sinai, US) discusses the findings of a sub-study of the MANIFEST-PF registry.The study investigated the impact of left atrial posterior wall ablation during pulsed field ablation (PFA) for persistent atrial fibrillation.Questions1. What is the MANIFEST-PF registry?2. What is the importance of… View more
Author(s): Isabel Deisenhofer Added: 1 year ago
HRS 2024 — Prof Isabel Deisenhofer (German Heart Center Munich, Technical University of Munich, DE), investigator, joins us to discuss the findings from the TAILORED-AF trial (NCT04702451, Volta Medical).This randomised controlled trial compared a tailored ablation strategy targeting areas of patio-temporal dispersion in combination with pulmonary vein isolation (PVI) to anatomical ablation… View more
Author(s): Yury Malyshev Added: 1 year ago
AF Symposium 24 — Dr Yury Malyshev (Mount Sinai Hospital, US) joins us to discuss the findings from three studies focusing on the long-term effects of pulsed-field ablation (PFA) on coronary arteries.QuestionsWhat is known currently about the effect of PFA in Coronary Arteries? What is the importance of this topic?What was the study design and cohort?What are the key findings?Who are the take… View more
Added: 1 day ago Source:  AF Symposium
AF Symposium has announced a series of late-breaking scientific sessions scheduled for February 2026, featuring first-in-human data and pivotal trial results across pulsed field ablation (PFA), left atrial appendage (LAA) therapies, and advanced mapping technologies.These sessions will showcase cutting-edge clinical science presented by leading international investigators, with a strong focus on… View more
Author(s): Alan Bulava Added: 2 years ago
ESC 2023 — Dr Alan Bulava (Ceske Budejovice Hospital and University of South Bohemia, CZ) joins us in this succinct interview to discuss the findings from the SurHyb trial. The SurHyb study was a prospective, open-label-multicentre randomized trial. The study aimed to evaluate CryoMaze surgery alone, as compared to CryoMaze followed by radiofrequency catheter ablation 3-months post-surgery. … View more